MedTrace Logo

Gait and Bone Health in SMA

NCT07400198 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2026-03-18

No results posted yet for this study

Summary

The objective of this study is to understand how spatiotemporal and kinetic gait parameters are associated with bone health in pwSMA who are receiving DMT. We hypothesize that gait parameters are associated with BMD and can determine fracture risk in pwSMA. This is an observational study that involves one in-clinic visit (approximately 3 hours) with remote follow-up visits (approximately 15 minutes) every 3 months for 1 year to collect fracture and medical history. Each of the assessments included in this study are non-interventional and are not intended as a treatment nor are they at the level of standard of care.

Conditions

  • Spinal Muscular Atrophy Type 3
  • Ambulatory Spinal Muscular Atrophy

Sponsors & Collaborators

  • Biogen

    collaborator INDUSTRY

  • Jacqueline Montes

    lead OTHER

Eligibility

Min Age
8 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-05
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07400198 on ClinicalTrials.gov